Go to the list of all blogs
Jimmy Landsman's Avatar
published in Blogs
Aug 22, 2026
TickeronGET DAILY SIGNALS
Schwab U.S. Dividend Equity ETF (SCHD) +6.7% in a Month: Value Rotation and Income Focus

Schwab U.S. Dividend Equity ETF (SCHD) +6.7% in a Month: Value Rotation and Income Focus

Key Takeaways

  • Positioning: SCHD is a passively managed exchange-traded fund (ETF) that tracks the Dow Jones U.S. Dividend 100 Index and holds roughly 103 U.S. dividend-paying companies.
  • Performance: The fund rose approximately 6.7% over the trailing month and about 8.6% over the trailing three months through mid-August 2026.
  • Portfolio character: Sector exposure is concentrated in health care, consumer staples, energy, and financials, with a smaller technology allocation than broad market indexes.
  • Income and cost: The expense ratio is 0.06% and the trailing 12-month yield is roughly 3.3%, keeping the fund cost-competitive against both equity and fixed-income alternatives.
  • Principal watch points: Federal Reserve policy, long-term Treasury yields, energy prices, and rotation between growth and value are likely to remain the dominant influences.

SCHD Overview and Holdings

The Schwab U.S. Dividend Equity ETF is a passively managed exchange-traded fund that seeks to track the total return of the Dow Jones U.S. Dividend 100 Index. The underlying index screens for U.S. companies with established dividend records and ranks candidates using measures of cash flow, profitability, yield, and dividend growth. The fund generally invests at least 90% of its net assets in stocks included in the index.

SCHD held about 103 stocks as of mid-2026, with top positions that have recently included Abbott Laboratories (ABT), Amgen (AMGN), Merck (MRK), Coca-Cola (KO), UnitedHealth Group (UNH), Home Depot (HD), Procter & Gamble (PG), Chevron (CVX), Verizon Communications (VZ), and PepsiCo (PEP). Sector allocation is anchored in health care and consumer staples—each roughly 20% of assets—followed by energy, industrials, financials, information technology, consumer discretionary, and communication services. Utilities represent only a marginal weight.

The fund’s 0.06% expense ratio and approximately $100 billion in assets under management make it one of the largest and lowest-cost dividend-focused ETFs. This structure produces a value-and-income portfolio: the index emphasizes current income and financial strength rather than high-growth technology leadership, which helps explain the fund’s relatively measured, dividend-supported return pattern. I also checked this using Tickeron’s AI Screener to see how the holdings compare across similar dividend strategies.

Industry and Thematic Landscape

The market environment around SCHD has been defined by rotation rather than a single dominant theme. Mega-cap technology and artificial intelligence leadership cooled in mid-2026, while value, energy, and income-oriented segments attracted more attention. Longer-term Treasury yields have stayed elevated, with the 10-year yield near 4.7%, making dividend-paying equities compete more directly with bonds for investor capital.

Inflation has remained above the Federal Reserve’s long-term objective, and the central bank has maintained a cautious, data-dependent stance. That backdrop has supported cash-generative sectors with pricing power, including parts of health care, consumer staples, and energy. Energy exposure has been a particularly important swing factor: firm crude prices and geopolitical risk in the Middle East have supported upstream earnings, while short-term oil price pullbacks have periodically weighed on the sector.

Health care and consumer staples—SCHD’s largest sector blocks—have offered relatively steady demand and strong balance sheets. Financials have benefited from higher interest margins, while utilities and real estate, two rate-sensitive income groups, have faced more pressure. SCHD’s near-zero utility allocation has limited that drag.

Performance and Positioning Snapshot

Through mid-August 2026, SCHD rose about 6.7% over the trailing month, moving from roughly $32.34 to $34.52 based on closing prices. The advance was gradual, with the fund establishing higher lows rather than a sharp vertical move. Over the trailing three months, the fund gained approximately 8.6%, extending a broad advance from mid-May.

The fund’s recent performance reflects its sector mix. Energy, industrials, and information technology holdings delivered strong year-to-date contributions into mid-2026, while health care and financials improved over the latest three-month stretch. Consumer staples have provided steadier, less dramatic performance. Because SCHD is underweight mega-cap technology relative to the broad market, it has not fully captured AI-led rallies; however, that same structure has made its returns less dependent on a narrow group of growth stocks and more tied to earnings durability, dividends, and valuation.

2026 Outlook and Key Factors to Monitor

For the remainder of 2026, the most important factors for SCHD are likely to be monetary policy and the direction of long-term yields. If inflation remains sticky and the Federal Reserve keeps policy restrictive, dividend equities will face continued competition from fixed income; if rate expectations ease, income-oriented stocks may become relatively more attractive.

Energy prices, Middle East supply risks, and the earnings trajectory of large integrated oil holdings will remain key swing factors. Health care policy, drug pricing headlines, and the resilience of managed care and pharmaceutical earnings will influence the fund’s largest sector exposure. Consumer staples companies must demonstrate that pricing power and input costs remain manageable.

Investors should also monitor dividend ETF flows, value-versus-growth rotation, and the payout growth of major holdings. Risks include an economic slowdown that pressures cyclical energy and financials, a sharp rise in long-term rates, or a return to narrow mega-cap technology leadership that leaves dividend-oriented portfolios lagging. No single catalyst is likely to dominate; the fund’s path will depend on the balance among these themes.

AI Tools in Portfolio Research

In my own workflow, I occasionally turn to Tickeron’s AI Screener when comparing dividend ETFs like SCHD against peers. The platform lets users apply technical indicators, fundamentals, volatility measures, and AI-generated signals to scan and filter thousands of securities efficiently. It has helped me surface comparable holdings and assess sector momentum without manual data crunching. Explore the AI Screener to refine your ETF and equity research workflow.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: SCHD

Contributor

My name is Jimmy, and I’m a financial analyst focused on identifying compelling opportunities across the ETF market. Each day, I analyze hundreds of ETFs to uncover potential trading and investment opportunities using a broad range of market factors. For short-term trading, I rely heavily on technical analysis, including price channels, momentum indicators, support and resistance levels, trend patterns, and other market signals. At the same time, I dedicate significant attention to evaluating ETFs from a long-term investment perspective. My objective is to build a well-balanced ETF portfolio that combines core investment holdings with more tactical and speculative positions. The goal is to create a portfolio that can participate effectively in market rallies while also remaining resilient during periods of volatility and market corrections.


SCHD sees MACD Histogram crosses below signal line

SCHD saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on November 16, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 45 instances where the indicator turned negative. In 37 of the 45 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 82%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for SCHD moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 42 similar instances where the indicator moved out of overbought territory. In 29 of the 42 cases, the stock moved lower in the following days. This puts the odds of a move lower at 69%.

The Momentum Indicator moved below the 0 level on November 16, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on SCHD as a result. In 50 of 82 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 61%.

SCHD moved below its 50-day moving average on November 19, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SCHD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 71%.

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

The 10-day moving average for SCHD crossed bullishly above the 50-day moving average on October 22, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 16 of 19 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 84%.

Following a +1.04% 3-day Advance, the price is estimated to grow further. Considering data from situations where SCHD advanced for three days, in 265 of 318 cases, the price rose further within the following month. The odds of a continued upward trend are 83%.

SCHD may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In 285 of 363 cases where SCHD Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 79%.

Notable companies

The most notable companies in this group are Chevron Corp (NYSE:CVX), Coca-Cola Company (NYSE:KO), Procter & Gamble Company (NYSE:PG), Merck & Co (NYSE:MRK), Unitedhealth Group (NYSE:UNH), Home Depot (NYSE:HD), Texas Instruments (NASDAQ:TXN), Amgen (NASDAQ:AMGN), PepsiCo (NASDAQ:PEP), Abbott Laboratories (NYSE:ABT).

Industry description

The investment seeks to track as closely as possible, before fees and expenses, the total return of the Dow Jones U.S. Dividend 100™ Index. To pursue its goal, the fund generally invests in stocks that are included in the index. The index is designed to measure the performance of high dividend yielding stocks issued by U.S. companies that have a record of consistently paying dividends, selected for fundamental strength relative to their peers, based on financial ratios. The fund will invest at least 90% of its net assets in these stocks.

Market Cap

The average market capitalization across the Schwab US Dividend Equity ETF (SCHD) ETF is 57.94B. The market cap for tickers in the group ranges from 363.12M to 417.06B. CVX holds the highest valuation in this group at 417.06B. The lowest valued company is AMSF at 363.12M.

High and low price notable news

The average weekly price growth across all stocks in the Schwab US Dividend Equity ETF (SCHD) ETF was -6%. For the same ETF, the average monthly price growth was -2%, and the average quarterly price growth was 5%. GIS experienced the highest price growth at 4%, while VRTS experienced the biggest fall at -18%.

Volume

The average weekly volume growth across all stocks in the Schwab US Dividend Equity ETF (SCHD) ETF was 58%. For the same stocks of the ETF, the average monthly volume growth was 35% and the average quarterly volume growth was 17%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 66
P/E Growth Rating: 42
Price Growth Rating: 48
SMR Rating: 42
Profit Risk Rating: 60
Seasonality Score: 9 (-100 ... +100)
AI Robots 7
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
Interact to see
Advertisement
The ADR gapped lower in premarket trading and was at $335.71 in early regular-session trading, -4.65% from Thursday's close of $352.09. The move extends a global AI and chip unwind: investors are cutting crowded semiconductor bets on stretched valuations, rising sector debt, data-center opposition and Nvidia's leadership turmoil, and Nvidia's strong quarter failed to calm sentiment.
Micron shares slid from Thursday's $690.44 close to $635.41, a -7.97% loss, deepening during Friday's regular session after an already soft premarket. The decline was sector-driven, not company-specific: investors kept unwinding AI exposure as Anthropic fell back after its debut, while hawkish Fed comments and doubts about Nvidia's leadership and AI spending returns pressured chip valuations.
Meta Platforms fell from a $596.22 previous close to $583.40, a -2.15% move, with the decline built in premarket trading and held through early Friday action after Thursday's -3.27% drop. The drop was sector-driven, not company-specific: Anthropic slid roughly -6% to -10% premarket on its second trading day, reviving doubts that AI spending will generate returns, and AI-linked megacaps sold off broadly with Nasdaq 100 futures down about -1.5%.
ANT dropped from Thursday's record-debut close of $97.17 to about $88.56 in Friday premarket trading, a -8.86% move ahead of the opening bell, still above its $83 IPO price. The decline came from a broad AI and technology selloff rather than any Anthropic-specific disclosure: Nvidia and AMD traded lower premarket, index futures were sharply down, and renewed doubts over AI spending and valuations drove profit-taking after the +17.07% first-day gain.
IREN dropped -8.33% to $13.21 from Thursday's $14.41 close, with weakness building in premarket and extending through the first hour of regular trading. The decline extends a sector-wide neocloud rout: Anthropic's post-IPO slide and turmoil at Nvidia revived doubts about debt-funded AI data center spending, dragging CoreWeave and Nebius down with it; no IREN-specific news was released.